Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Dec:2:1-9.
doi: 10.1200/CCI.18.00045.

Assessing the Training and Research Environment for Genomics, Bioinformatics, and Immunology in Radiation Oncology

Affiliations

Assessing the Training and Research Environment for Genomics, Bioinformatics, and Immunology in Radiation Oncology

Kent W Mouw et al. JCO Clin Cancer Inform. 2018 Dec.

Abstract

Purpose: To assess radiation oncologists' perceptions of training and research opportunities in the fields of genomics, bioinformatics, and immunology.

Materials and methods: A 13-item electronic survey was sent to 101 radiation oncology department chairs and administrators. A separate 30-item electronic survey was sent to 132 members of the American Society for Radiation Oncology Science Council as well as to 565 members of the Association of Residents in Radiation Oncology. Survey responses were collected, and results were analyzed using descriptive statistics.

Results: Twenty-six department chairs and 91 general respondents submitted responses. Among general respondents, 69% were current trainees and 31% had completed training. The majority of respondents (92%) were affiliated with an academic/university main campus. Approximately half of respondents (43% to 53%) reported no prior formal training in bioinformatics, genomics, or immunology. More than half of department chairs (54% to 58%) and general respondents (57% to 63%) thought that current training opportunities in these areas were absolutely or moderately insufficient. A majority of respondents (53% to 65%) thought that additional training in these areas would provide opportunity for career advancement, and 80% could identify a current or future research project that additional training in these fields would allow them to pursue. More than half of respondents expressed interest in attending a formal training course, and the majority of department chairs (22 of 26 [85%]) reported that they would probably or definitely send trainees or faculty members to a formal training course.

Conclusion: Among radiation oncologists surveyed, there is a perceived lack of current training opportunities in bioinformatics, genomics, and immunology. A majority of respondents reported an interest in obtaining additional training in these areas and believed that training would provide opportunity for career advancement.

PubMed Disclaimer

Conflict of interest statement

Kent W. Mouw

Consulting or Advisory Role: Pfizer, EMD Serono

Tyler F. Beck

Other Relationship: National Cancer Institute (I)

Judith C. Keen

Stock and Other Ownership Interests: Johnson & Johnson

Adam P. Dicker

Leadership: Department of Defense-Prostate Cancer Research Program, NRG Oncology, American Society for Radiation Oncology

Consulting or Advisory Role: EMD Serono, Ferring, Janssen, RedHill Biopharma, Self Care Catalyst, Celldex, Johnson & Johnson

Research Funding: Prostate Cancer Foundation

Travel, Accommodations, Expenses: Merck KGaA, Ferring, Self Care Catalyst

Figures

Fig 1.
Fig 1.
Perceived sufficiency of current training environment for bioinformatics, genomics, and immunology. (A) Department chairs (n = 25 responses). (B) General respondents (n = 73 responses).
Fig 2.
Fig 2.
Perceived potential for career advancement and research opportunities with additional training. (A) Career advancement (n = 74 responses). (B) Specific research projects (n = 73 responses).
Fig 3.
Fig 3.
Assessing interest in a formal training course in bioinformatics, genomics, and immunology. (A) General respondents (n = 76 responses). (B) Department chairs (n = 25 responses).
Fig 4.
Fig 4.
Interest in additional training on the basis of extent of prior training. The percentage of respondents who were definitely or probably interested in taking formal training courses in bioinformatics, genomics, or immunology are shown. Responses are grouped by the type of previous training: no previous training, previous training in the specific area, or previous training in any of the areas (bioinformatics, genomics, or immunology).
Fig A1.
Fig A1.
Previous training in bioinformatics, genomics, and immunology (n = 74 responses). (A) Formal training in bioinformatics (BINF) by career stage. (B) Formal training in genomics (GENOM) by career stage. (C) Formal training in immunology (IMMUNO) by career stage.
Fig A2.
Fig A2.
Percentage of respondents who believe that current training opportunities in bioinformatics, genomics, and immunology are absolutely or moderately insufficient.
Fig A3.
Fig A3.
Respondents’ views on whether there are fewer training opportunities in bioinformatics, genomics, and immunology within radiation oncology than within other oncology specialties.

Comment in

References

    1. Garraway LA, Lander ES. Lessons from the cancer genome. Cell. 2013;153:17–37. - PubMed
    1. Berger MF, Van Allen EM. Delivering on the promise of precision cancer medicine. Genome Med. 2016;8:110. - PMC - PubMed
    1. LaFleur MW, Muroyama Y, Drake CG, et al. Inhibitors of the PD-1 pathway in tumor therapy. J Immunol. 2018;200:375–383. - PMC - PubMed
    1. Antonia SJ, Villegas A, Daniel D, et al. Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer. N Engl J Med. 2017;377:1919–1929. - PubMed
    1. Hall WA, Bergom C, Thompson RF, et al: Precision oncology and genomically guided radiation therapy: A report from the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference. Int J Radiat Oncol Biol Phys 101:274-284, 2018. - PubMed

Publication types

MeSH terms